Company: SUPN
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0001104659-25-042531
Chunk: 66

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 66
---
 refer to the Corporate Governance section of this Proxy Statement. Stockholders intending to present proposals at our 2026 Annual Meeting, and not intending to have such proposals included in our proxy statement for such meeting, must send their written proposal to the Secretary of Supernus at 9715 Key West Avenue, Rockville, Maryland 20850 no earlier than February 16, 2026 and no later than March 18, 2026, and such written proposal must be in accordance with the requirements set forth in our Amended and Restated Bylaws. If notification of a stockholder proposal is not received by the above date, we may vote, in our discretion. any and all of the proxies received in that solicitation. ANNUAL REPORT Our Annual Report to Stockholders (which includes our consolidated financial statements for the year ended December 31, 2024) accompanies this Proxy Statement. The Annual Report to Stockholders does not constitute a part of the proxy solicitation materials. 51 01 - Carrolee Barlow, M.D., Ph.D. 02 - Jack A. Khattar1 U P XFor Withhold For WithholdSupernus Pharmaceuticals, Inc.Proposals — The Board of Directors recommend a vote FOR all the nominees listed, FOR Proposals A 2 and 3, and AGAINST Proposal 4.045D8A2. to approve, on a non-binding basis, the compensation paid toour named executive officers;3. to ratify the appointment of KPMG LLP as our independentregistered public accounting firm for the fiscal year endingDecember 31, 2025;1. to elect two (2) directors to hold office for the ensuing three years and until their successors have been duly elected and qualified:For Against AbstainFor Against AbstainFor Against AbstainPlease sign exactly as name(s) appears hereon. Joint owners should each sign. When signing as attorney, executor, administrator, corporate officer, trustee, guardian, or custodian, please givefull title.Date (mm/dd/yyyy) — Please print date below. Signature 1 — Please keep signature within the box. Signature 2 — Please keep signature within the box.B Authorized Signatures — This section must be completed for your vote to count. Please date and sign below.4. to consider and vote upon a stockholder proposal, if includedin our Proxy Statement for the Annual Meeting of Stockholders(the “Proxy Statement”) and properly presented at themeeting; and5. to transact